Status:
COMPLETED
The Sexual Health of Rectal Cancer Patients
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
Albert Einstein College of Medicine
Icahn School of Medicine at Mount Sinai
Conditions:
Rectal Cancer
Rectum
Eligibility:
All Genders
21+ years
Brief Summary
We know that treatment for rectal, colorectal or anal cancer can impact sexual function. This study aims to learn: * How the treatment affects emotional and social well-being. * How a new sexual heal...
Detailed Description
This is a two year randomized clinical trial examining the feasibility, tolerability, acceptability (including adherence) and efficacy of an intervention designed to improve sexual functioning of surv...
Eligibility Criteria
Inclusion
- At least six months post radiation and/or surgery for stage I-III rectal adenocarcinoma or rectosigmoid for cancer with an anastomosis at 15 cm or below and completed treatment
- At least six months post radiation and/or chemotherapy for anal cancer.
- Have no evidence of disease or recurrence
- For women indicate Indicate moderate satisfaction or below on their overall sexual life (a score of "4" or lower on the question "Over the past 4 weeks, how satisfied have you been with your overall sexual life?"
- For men indicate, and a score of "3" or lower on the question "How would you rate your confidence that you could get and keep an erection" for men) and a score of "2" or higher on the question "How much does this problem bother you?
- In the judgment of the consenting professional interventionists, able to communicate in English well enough to work with English speaking and complete the study assessments.
- Age 21 years or older.
Exclusion
- Significant cognitive or psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a psychotherapeutic intervention.
- Are actively participating in protocol 06-151
- Participated in focus group or qualitative interview.
Key Trial Info
Start Date :
June 24 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 21 2024
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT00712751
Start Date
June 24 2008
End Date
November 21 2024
Last Update
November 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
New York, New York, United States, 10029
2
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065